About Daniel Ahlstedt
Form D filings for EnPlusOne Biosciences from 2022 to 2024 list Daniel Ahlstedt as chief operatingofficer and director.
Daniel Ahlstedt first appears on SEC filings in 2022.
Experience
This experience comes from SEC filings. The years are when the filings name Daniel Ahlstedt in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Daniel Ahlstedt works with at each company, as listed on that company's latest Form D.
EnPlusOne Biosciences Inc. · Form D/A, Dec 26, 2024
AL
Andrew Lee
Director
DW
Daniel Wiegand
Executive officer and director
SK
Steven Kasok
Director
DJ
Daniel Janse
Director